Related Experiment Video
Updated: Dec 28, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Pericardial Tamponade After Systemic Alteplase in Stroke and Emergent Reversal With Tranexamic Acid
Cynthia Romero1, Samuel Shartar1,2, Michael J Carr1
1Emory University Hospital, Department of Emergency Medicine, Atlanta, Georgia.
Abstract:
Alteplase, or tissue plasminogen activator (tPA), lyses clots by enhancing activation of plasminogen to plasmin. Conversely, tranexamic acid (TXA) functions by inhibiting the conversion of plasminogen to plasmin, which inhibits fibrinolysis. TXA has proven safe and effective in major bleeding with various etiologies. A 76-year-old male developed acute ischemic stroke symptoms. Systemic alteplase was administered and he showed clinical improvement. Shortly thereafter, the patient became hypotensive and lost pulses. Point-of-care ultrasound revealed cardiac tamponade. TXA was immediately given to inhibit fibrinolysis since cryoprecipitate and blood products were not immediately available. Pericardiocentesis was performed and successfully removed 200 milliliters of blood with return of pulses. Clinicians must consider TXA as a rapidly accessible antagonist of tPA's fibrinolytic effects.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pericarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care

